Form 4 for ADCT ADC Therapeutics SA
Accepted 2025-05-08 00:00:00 ET · period of report 2025-05-06 · accession 0001628280-25-024021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-08 | 2025-05-06 | ADCT | MALLIK AMEET | CEO, Dir | F - Tax | $1.29 | -26.8K | 1.55M | -2% | -$34.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-05-06 | F | D | 26,758 | $1.29 | 1,552,247 | D | — | — |